Literature DB >> 11168152

Rapid susceptibility testing of Mycobacterium tuberculosis by the Mycobacteria Growth Indicator Tube (MGIT AST SIRE).

E A Macondo1, F Ba, A Gaye-Diallo, N C Touré-Kane, O Kaïré, A Gueye-Ndiaye, C S Boye, S Mboup.   

Abstract

OBJECTIVE: To evaluate the reliability of the Mycobacteria Growth Indicator Tube (MGIT AST) for susceptibility testing of Mycobacterium tuberculosis.
METHODS: Seventy strains of M. tuberculosis were tested for susceptibility to streptomycin, isoniazid, rifampicin and ethambutol by comparing MGIT AST results to those obtained by the method of proportion (MOP) on Lowenstein-Jensen (LJ) and Middlebrook 7H10 media. The 7H10 MOP was considered the method of reference.
RESULTS: The turnaround time for MGIT AST was 6.2 days (5-10 days) and for MOP it was 18-21 days. With rifampicin, MGIT AST agreed for all isolates with both MOP. For streptomycin, MGIT AST and 7H10 MOP agreed for 64 isolates (91.4%); 61 were susceptible and three resistant. LJ MOP and 7H10 MOP agreed for 64 isolates (92.2%); 62 were susceptible and three resistant. With isoniazid, both MOP agreed for all isolates, while MGIT AST and 7H10 MOP had two discrepancies. For ethambutol, MGIT AST and 7H10 MOP were concordant for 66 isolates; 65 were susceptible and one resistant. Both MOP were concordant for 67 isolates; 66 were susceptible and one resistant.
CONCLUSIONS: Based on these results, MGIT AST is a time-saving method and can be used as an alternative to the BACTEC System. MGIT AST is reliable as far as rifampicin and isoniazid are concerned; however, additional studies are needed for streptomycin and ethambutol.

Entities:  

Mesh:

Year:  2000        PMID: 11168152     DOI: 10.1046/j.1469-0691.2000.00094.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  5 in total

1.  Performance of BACTEC 960 Mycobacteria growth indicator tube in the susceptibility testing of genetically characterized Mycobacterium tuberculosis isolates.

Authors:  H J Marttila; M Marjamäki; M K Viljanen; H Soini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-11-06       Impact factor: 3.267

2.  Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis.

Authors:  Pascale Bemer; Frantiska Palicova; Sabine Rüsch-Gerdes; Henri B Drugeon; Gaby E Pfyffer
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

3.  Comparison of the mycobacterium growth indicator tube method and the method of proportion for drug susceptibility testing of mycobacterium tuberculosis.

Authors:  Ayse Esin Aktas; Nimet Yigit; Ahmet Ayyildiz; Ayse Bastopcu
Journal:  Eurasian J Med       Date:  2014-06

4.  Multicenter evaluation of the MB/BACT system for susceptibility testing of Mycobacterium tuberculosis.

Authors:  Pascale Bemer; Thomas Bodmer; Juerg Munzinger; Monique Perrin; Véronique Vincent; Henri Drugeon
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

5.  The MTB/MDR ELITe MGB® Kit: Performance Assessment for Pulmonary, Extra-Pulmonary, and Resistant Tuberculosis Diagnosis, and Integration in the Laboratory Workflow of a French Center.

Authors:  Elisabeth Hodille; Charlotte Genestet; Thomas Delque; Luna Ruffel; Yvonne Benito; Isabelle Fredenucci; Jean-Philippe Rasigade; Gérard Lina; Oana Dumitrescu
Journal:  Pathogens       Date:  2021-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.